However, since chronic inflammation of the intestinal mucosa is the primary vehicle which ultimately leads to CRC, a growing number of studies, albeit partly discordant, have shown involvement of the innate immunity, in particular a misregulated NLRP3 activation, in the onset of this disease [115–118]. This evidence concerns the gene NLRP3 and colorectal carcinoma.